PlainRecalls
FDA Drug Critical Class I Ongoing

Fentanyl Transdermal System CII, 25mcg/h, packaged in a pouch, further packaged in 5-count carton, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058, Manufactured by: Kindeva Drug Delivery L/P, Northridge, CA 91324, NDC 47781-424-47.

Reported: February 26, 2025 Initiated: January 31, 2025 #D-0245-2025

Product Description

Fentanyl Transdermal System CII, 25mcg/h, packaged in a pouch, further packaged in 5-count carton, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058, Manufactured by: Kindeva Drug Delivery L/P, Northridge, CA 91324, NDC 47781-424-47.

Reason for Recall

Defective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch.

Details

Recalling Firm
Alvogen, Inc
Units Affected
112,128 cartons (5 pouches/carton)
Distribution
USA Nationwide
Location
Morristown, NJ

Frequently Asked Questions

What product was recalled?
Fentanyl Transdermal System CII, 25mcg/h, packaged in a pouch, further packaged in 5-count carton, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058, Manufactured by: Kindeva Drug Delivery L/P, Northridge, CA 91324, NDC 47781-424-47.. Recalled by Alvogen, Inc. Units affected: 112,128 cartons (5 pouches/carton).
Why was this product recalled?
Defective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 26, 2025. Severity: Critical. Recall number: D-0245-2025.